Support for autism research program, congressionally directed medical research programs (CDMRP)
Ended Awarded Last action
- Contract number
- W81XWH19F0181
- Awardee
-
Leidos, Inc. UEI QLNMVC12KWY3 Part of Leidos Holdings, Inc.
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $133,978
Award facts
- Opportunity
-
- W81XWH17R0036 Solicitation number
- Meeting, Scientific and Administrative Support Services (MSASS), Request for Proposal (RFP) Award Notice · Posted Apr 12, 2017
- Meeting, Scientific and Administrative Support Services Award Notice · Posted Mar 22, 2017
- Contract value 100% obligated
- $133,977.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 541690 Other Scientific and Technical Consulting Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Two Step
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$10,778 | |
| Supplemental Agreement for work within scope | -$20,500 | |
| Original award | $165,256 |
About this award
This federal contract award provides support for the Autism Research Program under the Congressionally Directed Medical Research Programs (CDMRP) administered by the Defense Health Agency (DHA). The $133,977.98 delivery order contract was awarded to Leidos, Inc., a global technology and engineering solutions provider, to support critical medical research programs. The contract is cost-plus-fixed-fee and was not set aside for a specific business category. Leidos, through its Leidos Services Operating Segment, is the prime contractor delivering research and program management services for this autism research initiative. The CDMRP is a major medical research program managed by the DHA that focuses on addressing high-priority topics directed by Congress, including conditions such as traumatic brain injury, cancer, and rare diseases.
Quick answers
Who was awarded contract W81XWH19F0181?
W81XWH19F0181 was awarded to Leidos, Inc. by Medical Command (Department of the Army) on May 1, 2019.
How much is contract W81XWH19F0181 worth?
The government has obligated $133,978 on W81XWH19F0181.
Which agency awarded contract W81XWH19F0181?
Medical Command (Department of the Army) awarded W81XWH19F0181, with funding from Defense Health Agency (Department of Defense).
Is contract W81XWH19F0181 an order under another contract?
Yes. W81XWH19F0181 is a delivery order under W81XWH17D0025, an indefinite delivery contract.
Was contract W81XWH19F0181 competed?
The extent of competition for W81XWH19F0181 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award